⏳ Fetching live dividend data...
Home › Calculator › ONCT Dividend Calculator 2026
Oncternal Therapeutics, Inc. · NASDAQ
Price: $0.53 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in ONCT → $282752954611513056.00M in 10 years · $23,556,689,111,919,867,000,000.00/month
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T) product candidate that targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. Oncternal Therapeutics, Inc. has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. has a research collaboration with Celularity Inc. to evaluate placental derived-cellular therapies targeting ROR1. The company is headquartered in San Diego, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime.
Ready to invest? Open ONCT position with:
Real after-tax yield depends on where you live and how you hold ONCT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 379.79% | 376.99% | $37,979 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 322.82% | 320.02% | $32,282 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 303.83% | 301.03% | $30,383 / yr |
| 🇬🇧 UK ISA | 0% | 379.79% | 376.99% | $37,979 / yr |
| 🇬🇧 UK Taxable | 8.75% | 346.56% | 343.76% | $34,656 / yr |
| 🇨🇦 TFSA | 0% | 379.79% | 376.99% | $37,979 / yr |
| 🇨🇦 CA Taxable | 25% | 284.84% | 282.04% | $28,484 / yr |
| 🇦🇺 Super (pension) | 15% | 322.82% | 320.02% | $32,282 / yr |
| 🇦🇺 AU Taxable | 30% | 265.85% | 263.05% | $26,585 / yr |
| 🇩🇪 DE Taxable | 26.375% | 279.62% | 276.82% | $27,962 / yr |
| 🇫🇷 FR Taxable | 30% | 265.85% | 263.05% | $26,585 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
ONCT pays quarterly — 4 times per year. Next ex-div: TBD.
How ONCT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ONCT sourced from FMP /financial-growth endpoint — real data, not estimates.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ONCT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →